Davita Healthcare Partners Stock News

DaVita Inc. found using ticker (DVA) have now 8 analysts in total covering the stock. The consensus rating is ''Hold''. The range between the high target price and low target price is between 207 and 113 calculating the mean target price we have 142.88. Given that the stocks previous close was at 98.84 this indicates there is a potential upside of 44.6%. The day 50 moving average is 108.63 and the 200 day MA is 116.42. The company has a market cap of $10,497m. Visit the company website at: /> [stock_market_widget type="chart" symbol="DVA" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

Exchange Traded Concepts LLC cut its stake in shares of DaVita Inc. (NYSE:DVA) by 5.3% in the 3rd quarter, Holdings Channel.com reports. The fund owned 4,285 shares of the companys stock after selling 238 shares during the period. Exchange Traded Concepts LLCs holdings in DaVita were worth $498,000 as of its most recent SEC filing. []

Sumitomo Mitsui DS Asset Management Company Ltd trimmed its stake in DaVita Inc. (NYSE:DVA) by 2.2% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 4,912 shares of the companys stock after selling 112 shares during the quarter. Sumitomo Mitsui DS Asset []

Stocks in Berkshire''s portfolio that are good companies at bargain prices Check out Warren Buffett Stock Picks » Download GuruFolio Report of Warren Buffett (Updated on 12/01/2021) , Check out Charlie Munger Stock Picks » Download GuruFolio Report of Charlie Munger (Updated on 12/01/2021) , Check out Larry Robbins Stock Picks » Download GuruFolio Report of Larry Robbins (Updated on 12/01/2021) , Check out Jim Si Stock Picks » Download GuruFolio Report of Jim Si (Updated on 12/01/2021) Related Stocks: GL , DVA , MA , V , VZ , TMUS , TEVA , BMY , BRK.A , BRK.B ,

As investors grapple with market volatility over the new coronavirus variant, four stocks in Berkshire Hathaway Inc. ( BRK.A , Financial)( BRK.B , Financial) CEO Warren Buffett (Trades, Portfolio)'s e

The research study presented here is a brilliant compilation of different types of analysis of critical aspects of the global Ambulatory Care Services market. It sheds light on how the global Ambulatory Care Services Market is expected to grow during

DaVita's (DVA) latest study indicates favorable outcomes for ESKD patients regarding the COVID-19 vaccines.

DaVita Inc (DVA) shares closed 0.1% lower than its previous 52 week low, giving the company a market cap of $9B. The stock is currently down 17.1% year-to-date, down 11.5% over the past 12 months, and up 53.9% over the past five years. This week, the Dow Jones Industrial Average fell 1.9%, and the S&P 500 fell 2.1%. Trading Activity Trading volume this week was 9.1% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.5. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -155.9% The company's stock price performance over the past 12 months lags the peer average by -123.9% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -70.3% lower than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

DVA, NVST, WWD, PHR, and ROAD have been added to the Zacks Rank #5 (Strong Sell) List on November 29, 2021

DVA, NVST, WWD, PHR, and ROAD have been added to the Zacks Rank #5 (Strong Sell) List on November 29, 2021

DaVita Inc. (NYSE:DVA) has been assigned a consensus rating of Hold from the nine research firms that are presently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation and one has issued a buy recommendation on the company. The average []

IFM Investors Pty Ltd cut its position in DaVita Inc. (NYSE:DVA) by 3.1% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 10,304 shares of the companys stock after selling 329 shares during the quarter. IFM Investors Pty Ltds holdings in DaVita were worth []

DaVita Inc (DVA) shares closed 1.3% lower than its previous 52 week low, giving the company a market cap of $10B. The stock is currently down 13.1% year-to-date, down 6.9% over the past 12 months, and up 61.1% over the past five years. This week, the Dow Jones Industrial Average fell 0.2%, and the S&P 500 fell 0.1%. Trading Activity Trading volume this week was 10.3% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.5. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -138.7% The company's stock price performance over the past 12 months lags the peer average by -113.2% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -70.4% lower than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

State of Alaska Department of Revenue increased its holdings in DaVita Inc. (NYSE:DVA) by 69.0% in the 3rd quarter, Holdings Channel reports. The fund owned 18,400 shares of the company’s stock after buying an additional 7,514 shares during the quarter. State of Alaska Department of Revenue’s holdings in DaVita were worth $2,138,000 as of its […]

DaVita Inc. (NYSE:DVA) Director Pamela M. Arway sold 446 shares of the stock in a transaction dated Tuesday, November 23rd. The stock was sold at an average price of $102.86, for a total value of $45,875.56. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. DVA []